Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

709 evidence items · page 26 / 29

62.3 %The prevalence of dental caries among female sex workers in Abidjan, Côte d'Ivoire was 62.3%.

Côte d'Ivoirecaries dentairesobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations

67.5 %Of 422 HIV-2-infected patients, 285 (67.5%) were treated with a boosted PI-based regimen.

Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations

165 cells/mm³The median CD4 count at antiretroviral therapy initiation among HIV-2 infected patients was 165 cells/mm³.

Côte d'IvoireVIH/sidapublished 2014BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/1471-2334-14-461

33.7 %In Côte d'Ivoire, the prevalence of high-risk HPV in HIV-uninfected women of childbearing age was 33.7%.

Côte d'Ivoirehigh-risk HPVHAL · Unilimdocument of 69 observations

17.7 aORHIV infection was associated with anogenital cancer (aOR 17.7 [CI 6.9-45.2]).

Côte d'Ivoireanogenital cancer · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations

100 cells/μLCD4 count ≤ 100 cells/μL at ART initiation was associated with TB-IRIS.

Côte d'IvoireTB-IRISpublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations

44 yearsThe median age at antiretroviral therapy initiation among HIV-2 infected patients was 44 years.

Côte d'IvoireVIH/sidapublished 2014BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/1471-2334-14-461

60 %Among HIV-2 patients, the prevalence of advanced HIV disease was 60.0% among those who were dead or lost to follow-up.

Côte d'IvoireVIH avancé · VIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

Patients who experienced severe morbidity had higher risks of mortality, virological failure and immunological failure.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

2.7 %Among the 975 first participants, 2.7% had active TB at baseline.

Côte d'Ivoiretuberculosepublished 2014PloS oneeurope_pmcdocument of 8 observations

3.2 %3.2% of patients were infected with both HIV1 and HIV2.

Côte d'IvoireHIV1 and HIV2published 2010Le Mali medicaleurope_pmcdocument of 17 observations

146 cells/mm³The median CD4 count at ART initiation was 146 cells/mm³ among dually seropositive patients.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

4,207 EU/mLTwenty-one days post-MVA-BN-Filo vaccination, geometric mean concentrations (GMCs) of EBOV GP binding antibodies in HIV-infected adults in the 28-day interval group were 4,207 EU/mL.

Côte d'Ivoiremaladie à virus Ebolapublished 2021PLoS medicineeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pmed.1003813

11.7 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of abortion was 11.7%.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

87 %The AA genotype represented 87% of the samples.

Côte d'Ivoirehemoglobinobserved 2022HAL · Unilimdocument of 23 observations

0.61 per_100_person_monthsDuring the post-intervention period, the malaria incidence rate was 0.61 cases per 100 person-months in the LLIN plus Bti group.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

84 %HIV-2 resistance mutations to nucleoside reverse transcriptase inhibitors were detected in 21 of 25 (84%) samples.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

From months 1 to 6, the percentage of women using a contraceptive method increased from 58% to 80% among HIV-1-infected adults on zidovudine + lamivudine + efavirenz.

Côte d'IvoireVIH/sidaobserved months 1 to 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50

16.7 %Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C).

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

60 %Among 1825 HIV-2-infected individuals initiating antiretroviral therapy, 60% were women.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

156 per_1000_person_yearsThe malaria incidence observed in this study was 156 cases per 1000 person-years.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

9.6 %HIV prevalence was 9.6% among TB cases among inmates at the Correctional and Detention Facility of Abidjan.

Côte d'Ivoiretuberculose · VIH/sidaobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations

13.4 %In Survey 3, malaria prevalence was 13.4% among 2913 participants.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

68.5 %The 36-month survival rate among ART-experienced HIV-2 patients with drug-resistant viruses was 68.5%.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

32.3 %A total of 10 (32.3%) HIV-2 patients died during follow-up.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.